$7.2M
in disclosed stock, −$213K (−2.89%) today
Live prices, last trade 2:55 PM ET
- Rank
- 11260th of 14,644
- Companies held
- 1
- Largest holding
- XBIT, 100.0% of total
- Latest SEC filing
- Nov 3, 2026
What the $7.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| XBiotech XBIT Common Stock | Directly | 4,261,690 | $1.68 | $7.2M | 100.0% | Form 4, Nov 3, 2026 |
Share counts are the amounts John Simard reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 11257 | Michael Chambers Director, Sarepta Therapeutics. Cambridge, MA | $7.2M |
| 11258 | Katie Casso Corporate Controller & CAO, Centene. St. Louis, MO | $7.2M |
| 11259 | Devin Cole Chief Operating Officer, Tyson Foods. Springdale, AR | $7.2M |
| 11260 | John Simard Director, XBiotech. Austin, TX | $7.2M |
| 11261 | Robert Zoellick Director, Robinhood Markets. Menlo Park, CA | $7.2M |
| 11262 | David A. Handler Director, PENN Entertainment. Wyomissing, PA | $7.2M |
| 11263 | Jon Ryan Ruhlman President, Preformed Line Products. Cleveland, OH | $7.2M |
Questions
How much stock does John Simard own?
John Simard holds $7,159,639 in listed stock based on SEC filings and current prices, mostly XBiotech (XBIT). That ranks 11260th on the Stock Rich List.
Is this John Simard's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John Simard last buy or sell stock?
The most recent open-market trade on file is a purchase of 70,000 XBIT shares on Nov 3, 2026 at $2.05.